A Look Back at the Top 5 Posts of 2014 Reply

Thus far in 2014, we’ve published 37 blog posts and attracted over 15 thousand visitors to the Lilly Clinical Open Innovation (LCOI) blog. Now that 2014 is drawing to a close, we’ve compiled a list of our most popular posts this year. Take a look and see if there are any that you missed.

1. Patient Participation in Clinical Trials Infographic

Our most popular post of 2014 featured an infographic about clinical trial participation. The Patient Participation in Clinical Trials infographic walks viewers through some of the reasons why people do and do not participate in clinical trials. While a relatively small percentage of oncology patients were aware of relevant clinical trials when they considered treatment options – only 16% – the overwhelming majority of clinical trial participants would consider joining another trial in the future.

Patient_Participation_in_Clinical_Trials_Infographic_«_Lilly_Clinical_Open_Innovation

More…

A Guide to the Lilly COI API

Lilly COI API

Click the image to view an infographic about the Lilly COI API

Click to enlarge the infographic.

Click to enlarge the infographic.

As the Internet continues to mature and more people access the web through desktop and mobile apps, the need for APIs (Application Programming Interfaces) has never been more pressing. APIs provide a consistent, easy-to-use way for developers to access data that can be built into mobile apps or websites.

Since 2005, ProgrammableWeb has cataloged the world’s APIs and has become the de facto journal of the API economy. Today there are more than 12,000 APIs listed in the ProgrammableWeb directory, but only 2.07% of those APIs are health-related. Clinical research-related APIs are hardly present at all, accounting for just 0.07% of the APIs listed on ProgrammableWeb.

The Lilly COI API is at the center of our efforts to make it easier for people to find clinical trials that are right for them or their loved ones. The API was created to make publicly-available clinical trial information easier for people to understand and easier for developers to work with.

More…

Rahlyn Gossen’s Unique Perspective On Clinical Trials Reply

Rahlyn GossenWe’re privileged to be working with Rahlyn Gossen, founder of Rebar Interactive, a digital strategy consultancy serving the clinical research industry. Rebar Interactive creates empowering (and award-winning) digital experiences for patients and professionals. Rahlyn’s digital marketing expertise spans a variety of areas, including search, social media, and mobile. Her work is infused with a patient-centric perspective, honed during Rahlyn’s time as a clinical research coordinator.

Rahlyn publishes a widely-read clinical trial blog and newsletter focusing on digital strategy, the patient experience, and innovation. The same topics are explored in 140 characters or less on Rebar Interactive’s Twitter account. Rahlyn also serves on the editorial advisory board of Applied Clinical Trials. Rahlyn is a proud New Orleanian and a connoisseur of cute online animal videos, particularly those of the feline variety.  

Tell me a little bit about yourself, and the path you’ve been on to make clinical research better.

More…

Another Milestone In Our Patient-Centric Development 2

The LVJJstudy.com website is a pilot project to improve how we inform patients about clinical trials.

The LVJJstudy.com website is a pilot project to improve how we inform patients about clinical trials.

At Lilly COI we spend plenty of time exploring the future of clinical trials. We continue to explore clinical trial matching, Internet-based studies, mobile health in trials, and other possibilities. Though we are excited by these possibilities, we also know that it will take some time for possibilities to fully morph into practicalities. Technologies need to improve, regulatory questions need to be answered, and clinical trial models need to evolve. Meanwhile, patients are in great need of an improved clinical trial experience today. We can’t ask patients to wait on a convergence of ideal conditions, especially when there are feasible improvements that we can make now.

More…